Anavex Life Sciences Corp.AVXLNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank71
3Y CAGR-11.7%
5Y CAGR+28.5%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-11.7%/yr
vs +59.7%/yr prior
5Y CAGR
+28.5%/yr
Recent deceleration
Acceleration
-71.4pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
3.5x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $102.58M | -22.4% |
| 2024 | $132.19M | -12.5% |
| 2023 | $151.02M | +1.3% |
| 2022 | $149.16M | -1.9% |
| 2021 | $152.11M | +420.0% |
| 2020 | $29.25M | +31.8% |
| 2019 | $22.19M | -3.2% |
| 2018 | $22.93M | -16.4% |
| 2017 | $27.44M | +198.7% |
| 2016 | $9.19M | - |